Refined Functional Carbohydrates Market to hit $300 million by 2025: Global Market Insights, Inc.

NASDAQ Market News June 28, 2019

NASDAQ Market News
Click here to email author

CHMP recommends EU approval of Roche’s Tecentriq in combination with Abraxane as an initial treatment for people with PD-L1-positive, metastatic triple-negative breast cancer

Chi-Med Announces Pricing of Upsized U.S. Public Secondary Offering of American Depositary Shares

Ads